NEUROLOGICAL DISEASES, NEUROSCIENCE & MENTAL HEALTH

Cerebrovascular Diseases

Main lines of research

SECONDARY PREVENTION (Coordinator: Pol Camps)

  • Cerebrovascular Complications of Carotid Atheromatosis. Study of Atheromatous Plaque Vulnerability – Pol Camps
  • Prevention of Cardiovascular Events in Patients with Intracranial Hemorrhage and Atrial Fibrillation (ENRICH-AF) – Joan Martí
  • Prevention of Cardiovascular Events in Patients with Lobar Intracerebral Hemorrhage Taking Statins (SATURN) – Joan Martí
  • National Registry of Carotid Web – Marina Guasch

INTRACRANIAL HEMORRHAGE (Coordinators: Luis Prats & Anna Ramos)

  • Intracerebral Hemorrhage due to Anticoagulants – Luis Prats
  • Endovascular Treatment to Prevent Hematoma Growth in the Acute Phase – Luis Prats
  • Perilesional Edema in Patients with Spontaneous Intracerebral Hemorrhage – Anna Ramos
  • Management of Patients with Subarachnoid Hemorrhage – Anna Ramos

REPERFUSION TREATMENTS (Coordinator: Pol Camps)

  • Benefits and Risks of Intravenous Thrombolysis and Endovascular Treatment – Pol Camps
  • Blood Pressure Management After Endovascular Treatment in Patients with Ischemic Stroke and Large Vessel Occlusion – Pol Camps

OTHERS (Coordinator: Pol Camps)

  • Non-Invasive Monitoring of Cerebral Blood Flow Using Optical Methods – Anna Ramos
  • Relevance of the Microbiota in Cerebrovascular Diseases – Luis Prats
  • Relevance of Genetic Factors in Cerebrovascular Diseases – Pol Camps
  • Participation in Clinical Trials – Pol Camps

Challenges

  • Enhance cooperation with other groups in the framework of Spanish stroke research.
  • Network (RETICS/INVICTUS) and also intrahospital cooperation (the Catalan Institute of Cardiovascular Sciences and the Haemostasis-Thrombosis group) and extra-hospital cooperation (with groups managed by Dr. García-Verdugo in Valencia, Dr. Arús at the Autonomous University of Barcelona, Dr. Anna Planas at Clinic Hospital, Dr. Turgut Durduran at ICFO). To obtain funding from FIS, regional authorities and private companies.
  • Increase the number of contracted and grant-aided researchers and professionally develop existing researchers.

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information